Provided by Tiger Trade Technology Pte. Ltd.

Karyopharm Therapeutics

1.93
-0.1300-6.31%
Volume:117.96K
Turnover:233.13K
Market Cap:43.74M
PE:-0.15
High:2.04
Open:2.02
Low:1.93
Close:2.06
52wk High:10.99
52wk Low:1.79
Shares:22.66M
Float Shares:17.07M
Volume Ratio:1.21
T/O Rate:0.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-13.0816
EPS(LYR):-17.9300
ROE:-891.05%
ROA:-47.61%
PB:-0.13
PE(LYR):-0.11

Loading ...

Oct 31, 2024

Major Issues Report

Form 8-K - Current report
Oct 25, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Sep 18, 2024

Major Issues Report

Form 8-K - Current report
Aug 29, 2024

Major Issues Report

Form 8-K - Current report
Aug 06, 2024

Major Issues Report

Form 8-K - Current report
Aug 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 05, 2024

Correspondence

Form CORRESP - Correspondence
May 31, 2024

Major Issues Report

Form 8-K - Current report
May 30, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 23, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
May 14, 2024

Major Issues Report

Form 8-K - Current report
May 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2024

Major Issues Report

Form 8-K - Current report
May 08, 2024

Major Issues Report

Form 8-K - Current report
Apr 04, 2024

Correspondence

Form CORRESP - Correspondence
Feb 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 29, 2024

Major Issues Report

Form 8-K - Current report
Feb 20, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]